Calcineurin-inhibitor induced pain syndrome after stem cell transplant.

Calcineurin inhibitors (CNIs) form the backbone of immunosuppressants used for graft-versus-host disease (GVHD) prophylaxis after allogeneic hematopoietic stem cell transplant (allo-HCT). Although ...